Laman UtamaGBM • FRA
add
Inovio Pharmaceuticals
Tutup sebelumnya
€3.80
Julat hari
€3.85 - €3.85
Julat tahun
€3.69 - €12.14
Permodalan pasaran
107.75J USD
Bilangan Purata
105.00
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | — | — |
Perbelanjaan pengendalian | 27.35J | 175.54% |
Pendapatan bersih | -25.17J | 25.83% |
Margin untung bersih | — | — |
Pendapatan bagi setiap syer | -0.89 | 42.95% |
EBITDA | -26.93J | -10.37% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 84.80J | -49.36% |
Jumlah aset | 107.06J | -44.56% |
Jumlah liabiliti | 33.52J | -38.99% |
Jumlah ekuiti | 73.54J | — |
Syer tertunggak | 26.10J | — |
Harga kepada buku | 1.35 | — |
Pulangan pada aset | -56.77% | — |
Pulangan pada modal | -69.87% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -25.17J | 25.83% |
Tunai daripada operasi | -27.44J | 5.73% |
Tunai daripada pelaburan | 14.08J | 356.25% |
Tunai daripada pembiayaan | 660.65K | -5.44% |
Perubahan bersih dalam tunai | -12.70J | 62.53% |
Aliran tunai bebas | -17.47J | 10.73% |
Perihal
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Diasaskan
1999
Tapak web
Pekerja
127
